Literature DB >> 19585506

Melanocortin receptor 1 variants and melanoma risk: a study of 2 European populations.

Dominique Scherer1, Eduardo Nagore, Justo Lorenzo Bermejo, Adina Figl, Rafael Botella-Estrada, Ranjit Kumar Thirumaran, Sabrina Angelini, Kari Hemminki, Dirk Schadendorf, Rajiv Kumar.   

Abstract

Variation within the melanocortin receptor 1 (MC1R) gene, that influences phenotypic traits and susceptibility to melanoma, is abundant across the populations. We assessed and compared the risk of melanoma in 2 European populations, German and Spanish, by genotyping MC1R variants through direct DNA sequencing from 1,185 melanoma cases and 1,582 controls. The presence of any variant in both populations was associated with a significantly increased risk of melanoma (odds ratio OR = 1.67, 95% confidence interval CI 1.40-1.99). The population attributable fractions (PAF) associated with the MC1R variants in both populations was over 25%. However, the results showed a statistically significant (p < 0.0001) higher frequency of MC1R variants in the German (70%) than in the Spanish population (60%). The red-hair colour (RHC) variants, though associated with increased risk in both populations, were more common in the German than in the Spanish population (p < 0.0001). Interestingly, non-RHC variants increased the disease risk in the Spanish (OR = 1.60, 95% CI 1.20-2.14) but not in the German population (OR = 1.07, 95% CI 0.80-1.44). Although RHC variants explained a major proportion of the observed PAF in the German population, in the Spanish population the major contributor to the PAF was the non-RHC V60L variant. We also observed reduced historic linkage disequilibrium between the variants V92M and T314T in the gene in German melanoma cases. In conclusion, our data underscored the unambiguous importance of the MC1R variants towards the population burden of melanoma. However, the variants that are associated with the disease differ between the investigated populations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19585506     DOI: 10.1002/ijc.24548

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  25 in total

1.  Critique of the International Agency for Research on Cancer's meta-analyses of the association of sunbed use with risk of cutaneous malignant melanoma.

Authors:  William B Grant
Journal:  Dermatoendocrinol       Date:  2009-11

2.  The p. R151C Polymorphism in MC1R Gene Modifies the Age of Onset in Spanish Huntington's Disease Patients.

Authors:  Gemma Tell-Marti; Joan Anton Puig-Butille; Pol Gimenez-Xavier; Ariadna Segu-Roig; Miriam Potrony; Celia Badenas; Victoria Alvarez; José M Millán; María José Trujillo-Tiebas; María A Ramos-Arroyo; Montserrat Milà; Susana Puig
Journal:  Mol Neurobiol       Date:  2016-12-06       Impact factor: 5.590

3.  Pharmacologic induction of epidermal melanin and protection against sunburn in a humanized mouse model.

Authors:  Alexandra Amaro-Ortiz; Jillian C Vanover; Timothy L Scott; John A D'Orazio
Journal:  J Vis Exp       Date:  2013-09-07       Impact factor: 1.355

4.  Interest and Uptake of MC1R Testing for Melanoma Risk in a Diverse Primary Care Population: A Randomized Clinical Trial.

Authors:  Jennifer L Hay; Kate Zielaskowski; Kirsten Meyer White; Kimberly Kaphingst; Erika Robers; Dolores Guest; Andrew Sussman; Yvonne Talamantes; Matthew Schwartz; Vivian M Rodríguez; Yuelin Li; Elizabeth Schofield; Jessica Bigney; Keith Hunley; David Buller; Marianne Berwick
Journal:  JAMA Dermatol       Date:  2018-06-01       Impact factor: 10.282

5.  Reciprocal responses of fibroblasts and melanocytes to α-MSH depending on MC1R polymorphisms.

Authors:  Hedwig Stanisz; Markus Seifert; Wolfgang Tilgen; Thomas Vogt; Knuth Rass
Journal:  Dermatoendocrinol       Date:  2011-10-01

6.  Melanoma: Stem cells, sun exposure and hallmarks for carcinogenesis, molecular concepts and future clinical implications.

Authors:  Athanassios Kyrgidis; Thrasivoulos-George Tzellos; Stefanos Triaridis
Journal:  J Carcinog       Date:  2010-04-01

7.  Melanoma genetic testing, counseling, and adherence to skin cancer prevention and detection behaviors.

Authors:  Karen Glanz; Kathryn Volpicelli; Peter A Kanetsky; Michael E Ming; Lynn M Schuchter; Christopher Jepson; Susan M Domchek; Katrina Armstrong
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-02-07       Impact factor: 4.254

8.  Risk factors for keratinocyte skin cancer in patients diagnosed with melanoma, a large retrospective study.

Authors:  Pablo Espinosa; Ruth M Pfeiffer; Zaida García-Casado; Celia Requena; Maria Teresa Landi; Rajiv Kumar; Eduardo Nagore
Journal:  Eur J Cancer       Date:  2015-12-17       Impact factor: 9.162

9.  Marshaling the Translational Potential of MC1R for Precision Risk Assessment of Melanoma.

Authors:  Peter A Kanetsky; Jennifer L Hay
Journal:  Cancer Prev Res (Phila)       Date:  2017-12-15

10.  Distribution of MC1R variants among melanoma subtypes: p.R163Q is associated with lentigo maligna melanoma in a Mediterranean population.

Authors:  J A Puig-Butillé; C Carrera; R Kumar; Z Garcia-Casado; C Badenas; P Aguilera; J Malvehy; E Nagore; S Puig
Journal:  Br J Dermatol       Date:  2013-10       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.